<DOC>
	<DOCNO>NCT02164422</DOCNO>
	<brief_summary>Evaluating effect guanfacine alcohol consumption . The investigator hypothesize guanfacine versus placebo decrease number drink consume 2-hour self-administration period across stress neutral/relaxing condition .</brief_summary>
	<brief_title>Does Guanfacine Attenuate Stress-Induced Drinking ?</brief_title>
	<detailed_description />
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>Age 2165 Able read write English Meets Diagnostic Statistical Manual Mental Disorders ( DSMIV ) criteria current ( past 6 month ) alcohol abuse alcohol dependence Participants significant current medical condition , seizure , delirium hallucination , unstable medical condition include HIV Current DSMIV abuse dependence substance , alcohol abuse , alcohol dependence , nicotine dependence Women pregnant nursing Suicidal , homicidal evidence current ( past 6month ) mental illness Meet DSMIV criterion current ( past6 month ) attention deficit hyperactivity disorder ( ADHD ) Specific exclusion administration guanfacine already specify include : EKG evidence baseline screen clinically significant conduction abnormality arrhythmias ; know intolerance guanfacine alpha blocker ; history fainting , syncopal attack , heart failure myocardial infarction , impair liver indicate aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) &gt; 3x normal renal function ( estimate creatinine clearance &lt; 60 cc/min ) ; treatment antihypertensive drug alphaadrenergic blocker ; use central nervous system ( CNS ) depressant ( e.g. , phenothiazine , barbiturate , benzodiazepine ) Subjects likely exhibit clinically significant alcohol withdrawal study . Individuals seek treatment drinking</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Alcohol</keyword>
	<keyword>Drinkers</keyword>
	<keyword>Guanfacine</keyword>
</DOC>